An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells
Nature Communications2013Vol. 4(1), pp. 1549–1549
Citations Over TimeTop 10% of 2013 papers
Antonio Filareto, Sarah Parker, Radbod Darabi, Luciene Borges, Michelina Iacovino, Tory Schaaf, Timothy Mayerhofer, Jeffrey S. Chamberlain, James M. Ervasti, R. Scott McIvor, Michael Kyba, Rita C. R. Perlingeiro
Related Papers
- → The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy(2019)44 cited
- → Utrophin localization in normal and dystrophin-deficient heart.(1994)66 cited
- → Dystrophin and dystrophin-related protein (utrophin) distribution in normal and dystrophin-deficient skeletal muscles(1993)50 cited
- → Utrophin may be a precursor of dystrophin during skeletal muscle development(2000)34 cited
- → Dystrophin is replaced by utrophin in frog heart; implications for muscular dystrophy(1997)6 cited